Piramal Pharma has reported result for first quarter ended June 30, 2025 (Q1FY26).
The company has reported 32.68% rise in its net profit at Rs 113.14 crore for the quarter ended June 30, 2025 as compared to Rs 85.27 crore for the same quarter in the previous year. The total income of the company increased by 4.62% at Rs 1150.80 crore for Q1FY26 as compared to Rs 1099.96 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported net loss of Rs 81.70 crore for Q1FY26 as compared to net loss of Rs 88.64 crore for the same quarter in the previous year. However, the total income of the company increased by 1.09% at Rs 1992.11 crore for Q1FY26 as compared to Rs 1970.68 crore for the corresponding quarter previous year.
